Albumin Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Albumin Market Size Analysis and Top Companies

The global albumin market size is projected to hit around USD 11.02 billion by 2033 increasing from USD 6.38 billion in 2023, with a CAGR of 5.62%. The top companies in the albumin market are Octapharma AG, Albumedix Ltd., Biotest AG, Grifols SA, HiMedia Laboratories, Medxbio Pte Ltd., CSL Limited, Merck KGaA, Takeda Pharmaceutical Company Limited, Ventria Bioscience Inc., and Others.

Market Report Coverage

Albumin Market Key Players

• Octapharma AG
• Albumedix Ltd.
• Biotest AG
• Grifols SA
• HiMedia Laboratories
• Medxbio Pte Ltd.
• CSL Limited
• Merck KGaA
• Takeda Pharmaceutical Company Limited
• Ventria Bioscience Inc.

Recent Developments

• In May 2023, American Regent, Inc. announced the launch of Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound), an alternative to Abraxane.
• In August 2022, Sartorius AG acquired Albumedix, Ltd., a manufacturer of recombinant human albumin-based products. This acquisition will help Sartorius AG strengthen its product portfolio in recombinant-based products.
• According to Aadi Bioscience, Fyarro (sirolimus protein-bound particles [albumin-bound]) was available in February 2022 to treat adult patients with metastatic malignant perivascular epithelioid cell tumors.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344